HHS Invites Feedback on Substance Privacy Paperwork
Published Date: 1/13/2026
Notice
Summary
The Department of Health and Human Services wants your thoughts on a new form to protect patient privacy about substance use disorder records. If you have ideas on how to make this form easier or clearer, now’s your chance to speak up before February 12, 2026. This new info collection won’t cost you money but aims to keep sensitive health info safe and sound.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
New Complaint Form to Protect SUD Records
The HHS Office for Civil Rights is creating a new ``Confidentiality of Substance Use Disorder Patient Records Complaint'' form so patients can file complaints about alleged violations of 42 CFR part 2. You can submit the form using the OCR online complaint portal, by downloading the form from OCR's website and submitting electronically, or by postal mail.
Time to File a Part 2 Complaint
HHS estimates that gathering information and completing the Part 2 complaint form will take 45 minutes per complaint. The Department estimates 1,864 complaints annually, totaling 1,398 burden hours per year (based on an assumption that 1 in 1,000 of 1,864,367 patients would file a complaint).
No Monetary Cost to Respondents
HHS states this new information collection will not cost individuals money while it aims to protect sensitive substance use disorder health information. The public may comment on the proposed collection through February 12, 2026.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16414, Adoption and Foster Care Analysis and Reporting System
This document withdraws a proposed rule that was published in the Federal Register on January 11, 2008. The proposed rule would have amended the Adoption and Foster Care Analysis and Reporting System (AFCARS) regulations at 45 CFR 1355.40 and the appendices to Part 1355 to modify the requirements for States to collect and report data to ACF on children in out-of-home care and in subsidized adoption or guardianship arrangements with the State. This document also withdraws the provision of the 2008 proposed rule that implemented the AFCARS penalty requirements of the Adoption Promotion Act of 2003 (Pub. L. 108-145).
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14709, Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction
This correction fixes some typos and technical mistakes in the 2027 health insurance rules under the Affordable Care Act. It mainly affects people and organizations involved in health coverage plans by clarifying when the rules take effect and restoring some important regulation details. These fixes take effect on July 20, 2026, ensuring smoother and clearer health plan operations next year.
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-12069, Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions
This new rule makes sure the groups that check Medicare providers play fair and follow clear rules to avoid conflicts of interest. It updates how psychiatric hospitals are reviewed and tightens rules for providers who lost their Medicare status but want back in. These changes affect Medicare providers and accrediting groups, start June 16, 2027, and aim to keep care safe and trustworthy.
Previous / Next Documents
Previous: 2026-00497, Commission Meeting
The Equal Employment Opportunity Commission is holding a public meeting on January 14, 2026, to change how they handle voting and clarify leadership roles. This affects employees and organizations watching how the agency runs. The meeting is open to everyone, with options to attend in person or listen by phone, and a transcript will be shared afterward.
Next: 2026-00500, Performance Review Board Members
The National Capital Planning Commission just named new members to their Performance Review Board for 2024-2026. This board checks how well senior executives are doing, suggests changes to their ratings, and recommends bonuses or pay raises. These appointments affect senior leaders and help keep performance reviews fair and on point over the next three years.